[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Masuoka N., Yoshimine C., Hori M., Tanaka M., Asada T., Abe K., Hisatsune T
Before you commit to a protocol, make sure you have a conversation about your specific needs and concerns
P-01 Hereditary angioedema with normal C1-INH and PLG muta-tion treated with tranexamic acid: Beware of the risk of thrombosis Alexis Bocquet, David Launay, Isabelle Boccon-Gibod, Aurlie Du-Thanh, Delphiine Gobert, Sbastien Sanges, Laurence Bouillet Launay &Sanges University of Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000, INSERM, and the Department of Internal Medicine and Clinical Immunology, CHU Lille, National Reference Center for Angioedema (CREAK), Lille, France Allergy, Asthma & Clinical Immunology 2025, 21(Suppl 2) :P-01 Introduction: The anti-fibrinolytic, tranexamic acid (TA) can be proposed as a long term prophylaxis for hereditary angioedema (HAE), and seems to be specifically efficient for HAE with plasminogen gene mutation (HAE-PLG), a subset of HAE with normal C1-INH (HAE-nC1-INH)
Cell Metab 25(1):152165
Mogelijke contaminatie
You may be getting oxygen through a thin tube that rests below your nose or a mask that covers your nose and mouth
